Vimab Group AB (OSTO:VIMAB) E10: kr-2.06 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
51 GF Score
Price kr2.97
GF Value kr6.01
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vimab Group AB E10?

Vimab Group AB OSTO:VIMAB +8.00% 51 E10 is kr-2.06 as of Mar. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 51/100 and a GF Value™ of kr6.01 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vimab Group AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.500. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-2.06 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-14), Vimab Group AB's current stock price is kr2.97. Vimab Group AB's E10 for the quarter that ended in Mar. 2026 was kr-2.06. Vimab Group AB's Shiller PE Ratio of today is .


Vimab Group AB  (OSTO:VIMAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vimab Group AB E10 Related Terms


Vimab Group AB E10 Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB E10 Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.18 -0.84 -1.86

Vimab Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.06 -1.34 -1.32 -1.86 -2.06

OSTO:VIMAB vs VRSK, EFX, BAH: E10 Comparison

For the Consulting Services subindustry, Vimab Group AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimab Group AB Shiller PE Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Vimab Group AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vimab Group AB's Shiller PE Ratio falls into.


OSTO:VIMAB
51GF Score
Vimab Group AB OSTO:VIMAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vimab Group AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.5/133.5600*133.5600
=-0.500

Current CPI (Mar. 2026) = 133.5600.

Vimab Group AB Quarterly Data

per share eps CPI Adj_EPS
201606 1.300 101.019 1.719
201609 -0.400 101.138 -0.528
201612 1.100 102.022 1.440
201703 -0.337 102.022 -0.441
201706 0.100 102.752 0.130
201709 -1.100 103.279 -1.423
201712 2.500 103.793 3.217
201803 1.800 103.962 2.312
201806 0.200 104.875 0.255
201809 0.100 105.679 0.126
201812 2.000 105.912 2.522
201903 1.100 105.886 1.387
201906 0.900 106.742 1.126
201909 -2.400 107.214 -2.990
201912 1.200 107.766 1.487
202003 0.006 106.563 0.008
202006 -14.600 107.498 -18.140
202009 1.500 107.635 1.861
202012 2.500 108.296 3.083
202103 1.300 108.360 1.602
202106 0.300 108.928 0.368
202109 0.300 110.338 0.363
202112 -3.517 112.486 -4.176
202203 -6.400 114.825 -7.444
202206 0.300 118.384 0.338
202209 -0.300 122.296 -0.328
202212 -0.807 126.365 -0.853
202303 -0.500 127.042 -0.526
202306 0.300 129.407 0.310
202309 0.200 130.224 0.205
202312 -0.300 131.912 -0.304
202403 -0.800 132.205 -0.808
202406 -0.200 132.716 -0.201
202409 -0.500 132.304 -0.505
202412 -1.900 132.987 -1.908
202503 -0.700 132.825 -0.704
202506 -0.400 133.699 -0.400
202509 -0.200 133.480 -0.200
202512 -2.100 133.390 -2.103
202603 -0.500 133.560 -0.500

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-2.06 mean?
Vimab Group AB (OSTO:VIMAB) has a E10 of kr-2.06 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vimab Group AB and its competitors.
Is Vimab Group AB's E10 too high?
Vimab Group AB's current E10 is kr-2.06. Overall, Vimab Group AB has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's E10 compare to VRSK and EFX?
Vimab Group AB's E10 of kr-2.06 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Business Services company?
A good E10 depends on the Business Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current E10 is kr-2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.01, compared to a current price of kr2.97 — trading 50.6% below its estimated fair value. The current E10 is kr-2.06. Vimab Group AB's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current E10 is kr-2.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr2.97 is trading 50.6% below its estimated GF Value™ of kr6.01. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • E10: kr-2.06
  • GF Value™: kr6.01 vs. price of kr2.97 (50.6% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
51GF Score

Get the complete analysis for OSTO:VIMAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.97
Price
kr6.01
GF Value